TrialOncoimmunology2024

Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

Stéphane Dalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.